Therapeutic attempts of ghrelin and ghrelin receptor agonists used in cancer cachexia [152,162,163,164] and chemoprevention of inflammation-associated CRC carcinogenesis in animal models [157], have given rise to the idea of including such a therapy in humans. The gene discussed is GHRL; the disease is colorectal carcinoma.